The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced European CE mark approval of the Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter for the treatment of cardiac ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

A letter signed by more than 17,000 doctors urges Senators to reject Robert F. Kennedy Jr. as HHS secretary, calling the ...

During the 66th American Society of Hematology Annual Meeting and Exposition, investigators revealed early-phase 1 data evaluating various BTK degraders that leverage different strategies to overcome ...

Take control of your health and participate in K-State Research and Extension’s upcoming Hypertension Awareness and ...

Participants are expected to attend the Kick-Off meeting on Tuesday, February 4, 2025, from 6:00 pm – 7:00 pm. Participants ...

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today ...